Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity.
Huanyu WangShimin WuYing WengXi YangLing HouYan LiangWei WuYanqin YingFeng YeXiaoping LuoPublished in: Italian journal of pediatrics (2024)
CES1 is associated with an increasing risk of MetS and MASLD and can be established as a biomarker for metabolic syndrome and MASLD of children with obesity.